When it comes to diagnosing sleep disorders like obstructive sleep apnea (OSA), choosing the right type of sleep study is essential. Whether you’re a pilot addressing FAA medical requirements, a commercial driver, or someone experiencing persistent fatigue or loud snoring, understanding the differences between Type I, II, and III studies can help you discuss the options with your healthcare provider.
The right choice depends on your symptoms, medical history, and any occupational documentation requirements.
Type I Sleep Study: Attended Laboratory Testing
A Type I sleep study, or attended polysomnography (PSG), is conducted in a sleep laboratory or hospital with a technician present. It captures detailed physiological data and allows staff to monitor the recording and address sensor problems during the study.
It typically monitors:
Brain waves (EEG).
Muscle activity (EMG).
Eye movements (EOG).
Heart rate and rhythm (ECG).
Airflow, oxygen levels, and respiratory effort.
Leg movements, body position, and snoring. [1]
An overnight laboratory visit can require additional scheduling and means sleeping in an unfamiliar environment. However, attended testing can be clinically important. AASM guidance recommends polysomnography rather than limited home sleep apnea testing for patients with certain conditions, including significant cardiorespiratory disease, suspected hypoventilation, chronic opioid use, a history of stroke, or severe insomnia. [2]
Type I testing should not be dismissed as excessive simply because someone needs a study for occupational purposes. The clinical assessment should guide the choice.
Type II Sleep Study: Comprehensive Testing at Home
A Type II study is unattended polysomnography, often performed at home. Like Type I testing, it includes signals used to assess sleep stages as well as breathing. Equipment and setup vary; not every Type II system is wireless or designed for patients to apply without assistance. [1]
Data recorded by the Onera Sleep Test System includes:
EEG, EOG, EMG, and ECG.
Respiratory flow and effort, and oxygen saturation.
Sound associated with snoring, movement, and body position. [3]
Effortless Sleep Diagnostics provides Type II at-home sleep testing for pilots using Onera’s patch-based technology. The Onera STS is FDA-cleared and designed for layperson application under the direction of a physician or trained technician. FDA clearance applies to the device; it does not guarantee FAA medical certification. [3]
A multicenter study comparing Onera STS with simultaneous laboratory PSG found similar performance for sleep staging and respiratory measures. That supports the device’s clinical use, but does not mean every home recording will be complete or identical to an attended study. [1]
Potential benefits of Type II testing include:
No overnight laboratory visit when home testing is appropriate.
Recording in a familiar sleeping environment.
Sleep-staging information alongside respiratory measurements.
A clinically interpreted report to share with your medical providers.
Cost, availability, and report turnaround depend on the provider and the patient’s circumstances. Our guide to preparing for an at-home sleep study explains the practical steps involved.
Type III Sleep Study: Focused Respiratory Testing
Type III studies generally record fewer signals than polysomnography, typically including:
Airflow.
Respiratory effort.
Heart rate.
Oxygen saturation.
Conventional Type III testing does not include the EEG-based sleep staging used in Type I and Type II studies. Without measured sleep time, respiratory events are generally reported against monitoring time, which can underestimate severity if the patient spends substantial time awake. [2]
Type III testing is more than a basic screening tool. AASM guidance supports technically adequate home sleep apnea testing for diagnosing OSA in uncomplicated adults whose signs and symptoms indicate an increased risk of moderate to severe OSA. It is not a general screening recommendation for low-risk patients. If a single home sleep apnea test is negative, inconclusive, or technically inadequate, the guideline recommends polysomnography. [2]
What Pilots Should Know About FAA Requirements
For testing requested under FAA OSA Specification Sheet B, the guidance identifies a Type I laboratory study or a Type II seven-channel home study providing comparable data and standards. The study must be interpreted by a sleep medicine specialist and include a diagnosis and treatment recommendations, if any. [4]
The FAA also describes a limited Type III exception in communities where Type II testing is unavailable. Under that exception, a positive study does not require further diagnostic testing before following the treatment pathway. Equivocal results may require a higher-level study unless a sleep medicine specialist documents why further testing is unnecessary. [4]
Before booking, confirm the appropriate study with your evaluating physician and AME. A test that is suitable for general clinical diagnosis may not meet every documentation requirement for your FAA case.
Choosing the Right Sleep Study
Type I, II, and III studies each have a role. Attended laboratory testing provides direct technical support, Type II offers comprehensive unattended recording, and Type III can answer a focused diagnostic question in appropriately selected patients.
For pilots, Type II can be a practical home-testing option when it meets the clinical and FAA requirements for the case. The best choice follows an evaluation of your needs rather than a blanket preference for one type.
If your physician or AME recommends Type II testing, contact the ESD team to discuss the process, availability, and report you will receive.